Seaport Therapeutics, INC 10-Q quarterly reports
Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.
NASDAQ
Seaport Therapeutics, Inc. filed its Form 10-Q for the quarter ended June 30, 2026, detailing increased R&D expenses and substantial operating losses, while noting sufficient cash runway into 2029.